Amgen Inc (AMGN)
Amgen Inc. is a global biopharmaceutical company focused on developing and manufacturing innovative medicines in areas such as oncology, nephrology, and inflammation. Founded in 1980, Amgen is known for its work in biologic therapies and has a strong portfolio of blockbuster drugs aimed at improving patient lives.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| September 12, 2025 | $2.38 | 2025-08-22 | 2025-08-22 |
| June 6, 2025 | $2.38 | 2025-05-16 | 2025-05-16 |
| March 7, 2025 | $2.38 | 2025-02-14 | 2025-02-14 |
| December 9, 2024 | $2.25 | 2024-11-18 | 2024-11-18 |
| September 6, 2024 | $2.25 | 2024-08-16 | 2024-08-16 |
Dividends Summary
- Amgen Inc has issued 57 dividend payments over the past 14 years
- The most recent dividend was paid 25 days ago, on September 12, 2025
- The highest dividend payed out to investors during this period was $2.38 per share
- The average dividend paid during this period was $1.32 per share.
Company News
Martin Capital Partners sold its entire 51,431 share stake in LyondellBasell Industries, valued at approximately $3 million, during Q3 2025. The fund's decision highlights potential challenges in the petrochemicals sector.
Immatics N.V. announced the appointment of Venkat Ramanan, Ph.D. as its new Chief Financial Officer, replacing Arnd Christ. Dr. Ramanan brings over 25 years of biopharmaceutical finance experience from companies like Seagen, Gilead Sciences, and Amgen.
European Medicines Agency's Committee recommended approval for two AstraZeneca drugs: Tezspire for chronic rhinosinusitis with nasal polyps and Koselugo for symptomatic, inoperable plexiform neurofibromas in NF1 patients.
Phoenix Group's £22 billion move from Aberdeen Group creates a potential investment opportunity in healthcare-focused closed-end funds with high dividend yields, particularly Abrdn Healthcare Investors and Abrdn Healthcare Opportunities Fund.
The article discusses the Invesco Large Cap Value ETF (PWV), which provides broad exposure to the large-cap value segment of the market. It highlights the fund's investment strategy, performance, and risk profile, as well as compares it to similar ETFs like Schwab U.S. Dividend Equity ETF (SCHD) and Vanguard Value ETF (VTV).
